Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
INTS compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
INTS
Intensity Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
INTS
Intensity Therapeutics, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only INTS
2
MRK
Merck
supplier
BMY
Bristol-Myers Squibb
supplier
Shared
0
No shared counterparties.
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
Role chip = supplier or customer
Source: SEC EDGAR
8 more · AMGN chain
›
INTS
Intensity Therapeutics, Inc.
Change
2.84
▼
−18.91%
· post 2.84
Mkt cap
$11.6M
Revenue
—
Revenue
—
AMGN
Amgen Inc
Change
461.49
▼
−3.55%
· post 460.22
Closed
Nov 5 '26
Mkt cap
$258.8B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
vs
Compare
Closed
Nov 5 '26
INTS
Intensity Therapeutics, Inc.
vs
AMGN
Amgen Inc
2.84
▼
−18.91%
post 2.84
Price
461.49
▼
−3.55%
post 460.22
$11.6M
Mkt cap
$258.8B
—
Revenue
$10.4B
Q3 FY26
—
Revenue
$36.8B
FY25
Change
Change
INTS
2.84
▼
−18.91%
vs
AMGN
461.49
▼
−3.55%
Closed
Nov 5 '26